Kera Capital Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Kera Capital Partners, Inc.
- $347 Billion
- Q4 2024
A detailed history of Kera Capital Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 1,332 shares of CRL stock, worth $224,069. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,332Holding current value
$224,069% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
691Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$856 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$629 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$358 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$326 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...